A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age

A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age

Conditions: Influenza, Human
Interventions: Combination Product: mRNA Seasonal Flu vaccine; Combination Product: Licensed Influenza Vaccine
Sponsors: GlaxoSmithKline
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 19, 2026Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments